ASSOCIATION BETWEEN C-REACTIVE PROTEIN (CRP) AND CELLULITIS IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
.
Abstract
Background: Cellulitis can be due to a variety of organisms, including Streptococcus and Staphylococcus species and presents itself as warm, red, swollen, and painful skin with the formation of pus. It commonly manifests in the ED, and differentiating IBD from DVT, contact dermatitis or Venous stasis dermatitis is sometimes challenging. There’s increased level of C- Reactive Protein (CRP), which is a liver protein that is manufactured during inflammation in conditions like infection, autoimmune disease and after trauma. Despite the association of CRP with cellulitis severity, there is limited literature on the diagnostic and prognostic potential of CRP in ED practice.
Objectives: This present research aims at assessing the correlation between the baseline CRP with the severity of cellulitis and to assess the applicability in clinical practice of this biomarker.
Methodology: This cross-sectional work-based study included 200 adult patients with cellulitis attending the ED of a tertiary care facility over a six-month period from February 2016 to July 2016. Serum CRP levels were determined before the onset of treatment at the 99th percentile with the high-sensitivity CRP assays, and the patients were divided into three groups: mild cellulitis, moderate cellulitis, severe cellulitis.
Results: These revealed CRP levels somewhat positively associated with cellulitis severity, r= 0.78, p < 0.001. Mild cellulitis cases had a median CRP of 15 mg/L (IQR: A normal/drinker situation was estimated to be 10–20 mg/L, moderate drinkers were 50 mg/L (IQR: 35–70 mg/L), and heavy drinkers 120 mg/L (IQR: 90–150 mg/L). The hospitalization rates are presented in figure 4 in comparison to CRP levels, reaching 0% in patients with CRP <20 mg/L and 90% in patients with CRP > 100 mg/L.Hospital complicated events such as abscess formation and sepsis occurred only in the setting of CRP > 100 mg/L.
Conclusion: The results corroborate the applicability of CRP in risk-stratifying cellulitis and forecasting complications as well as directing early management. Increased CRP levels relate with inflammation, hospitalization and adverse outcome. Consequently, the integration of CRP into clinical workflows can supplement patient care by alerting clinicians to cases that should be aggressive treat with a probability of recurrence.
Future works: The next research steps must consider serial CRP measurements for a comprehensive evaluation of this marker as well should correlate exact indicators such as procalcitonin. Implementation of CRP integration into EDs has the possibility of improving resource utilization and providing enhanced patients care.
References
2. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology [Internet]. 2018 Apr 13;9(754). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908901/
3. Goldberg I, Shalmon D, Shteinvil R, Berliner S, Paran Y, Zeltser D, et al. A second C-reactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP. Medicine. 2020 Oct 16;99(42):e22551.
4. Mouliou DS. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians. Diseases [Internet]. 2023 Dec 1;11(4):132. Available from: https://www.mdpi.com/2079-9721/11/4/132
5. Wiederhold AK, Cartuliares MB, Jeppesen K, Skjøt-Arkil H. Characteristics and Antibiotic Treatment of Patients with Cellulitis in the Emergency Department. Antibiotics [Internet]. 2024 Oct 30;13(11):1021. Available from: https://www.mdpi.com/2079-6382/13/11/1021
6. Herchline T. Cellulitis: Practice Essentials, Background, Pathophysiology [Internet]. Medscape.com. 2019. Available from: https://emedicine.medscape.com/article/214222-overview
7. Brindle RJ, Ijaz A, Davies P. Procalcitonin and cellulitis: correlation of procalcitonin blood levels with measurements of severity and outcome in patients with limb cellulitis. Biomarkers. 2018 Aug 23;24(2):127–30.
8. Escadafal C, Incardona S, Fernandez-Carballo BL, Dittrich S. The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. BMJ Global Health [Internet]. 2020 May 1;5(5):e002396. Available from: https://gh.bmj.com/content/5/5/e002396
9. Hassan A, Jabbar N. C-reactive Protein as a Predictor of Severity in Chronic Obstructive Pulmonary Disease: An Experience From a Tertiary Care Hospital. Cureus. 2022 Aug 21;
10. Yu H, Huang Y, Chen X, Nie W, Wang Y, Jiao Y, et al. High-sensitivity C-reactive protein in stroke patients – The importance in consideration of influence of multiple factors in the predictability for disease severity and death. Journal of Clinical Neuroscience. 2017 Feb;36:12– 9.
11. Fazal M. C-Reactive Protein a Promising Biomarker of COVID-19 Severity. The Korean Journal of Clinical Laboratory Science. 2021 Sep 30;53(3):201–7.
12. Rosen J, Yosipovitch G. Skin Manifestations of Diabetes Mellitus [Internet]. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK481900/
13. Australia H. Cellulitis [Internet]. www.healthdirect.gov.au. 2020. Available from: https://www.healthdirect.gov.au/cellulitis
14. Bailey E, Kroshinsky D. Cellulitis: diagnosis and management. Dermatologic Therapy. 2011 Mar;24(2):229–39.
15. Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nature Medicine [Internet]. 2019 Dec;25(12):1822–32. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147972/
16. Sullivan T, de Barra E. Diagnosis and management of cellulitis. Clinical Medicine [Internet]. 2019 Apr;18(2):160–3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303460/
17. Long B, Gottlieb M. Diagnosis and management of cellulitis and abscess in the emergency department setting: An evidence-based review. The Journal of Emergency Medicine. 2021 Oct;62(1).
18. Wallace HA, Waheed A, Perera TB. Necrotizing fasciitis [Internet]. Nih.gov. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430756/
19. Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MarjaA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft- tissue infections. World Journal of Emergency Surgery. 2018 Dec;13(1).
20. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases [Internet]. 2014 Jul 15;59(2):e10–52. Available from: https://academic.oup.com/cid/article/59/2/e10/2895845